Pregled bibliografske jedinice broj: 1261729
Post-COVID Telogen Effluvium
Post-COVID Telogen Effluvium // Acta Dermatovenerologica Croatica, 30(4) (2022), 220-226 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1261729 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Post-COVID Telogen Effluvium
Autori
Tešanović Perković, Deša ; Vukojević, Marija ; Bukvić Mokos, Zrinka
Izvornik
Acta Dermatovenerologica Croatica (1330-027X) 30(4)
(2022);
220-226
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
COVID-19 ; hair loss ; telogen effluvium ; pathophysiology, treatment
Sažetak
Recently, the number of patients with acute telogen effluvium (ATE), among other forms of hair loss, has increased in comparison with previous years. The COVID-19 pandemic, taking place during this period, may be the cause of this phenomenon. The exact mechanisms by which this virus causes hair loss are not entirely understood ; still, the most likely cause is an excessive release of proinflammatory cytokines during SARS-CoV-2 infection. This process can trigger the development of telogen effluvium (TE) by damaging hair matrix cells. Additionally, the psychosocial condition of patients recovering from COVID-19 will have deteriorated, contributing to hair loss. Based on data collected until now, post-COVID TE is expected to improve without any treatment. Although there is no specific treatment for post- COVID TE, eliminating psychophysical stress, managing systemic complications, and explaining the course of the condition to the patient will potentially improve and speed up the hair recovery process.
Izvorni jezik
Engleski
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE